A meta-analysis of scintimammography: An evidence-based approach to its clinical utility

Nuclear Medicine Communications

Volumn 27, Issue 7, 2006, Pages 589-594

  Hussain, Rahain ^a   Buscombe, John R ^a  

^a BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

Author keywords

99mTc MIBI meta analysis; Scintimammography

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M;

AGE DISTRIBUTION; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; EVIDENCE BASED MEDICINE; HUMAN; IONIZING RADIATION; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SCINTILLATION CAMERA; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMATIC REVIEW;

BREAST NEOPLASMS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MAMMOGRAPHY; PROGNOSIS; RADIONUCLIDE IMAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33748103874     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200607000-00007     Document Type: Review

References (42)

1. Cimitan M, Volpe R, Candiani E, Gusso G, Ruffo R, Borsatti E, et al. The use of thallium-201 in the preoperative detection of breast cancer: an adjunct to mammography and ultrasonography. Eur J Nucl Med 1995; 22:1110-1117.
2. Lee JK, Jao CH, Sun SS. Technetium-99m methylene diposphonate scintimammography for evaluation of palpable breast masses. Oncol Rep 1999; 6:659-663.
3. 99mTc-MDP: experience of the National Cancer Institute of Naples. Eur J Radiol 1998; 27:S275-S281.
4. Khalkhali I, Mena I, Jouanne E, Diggles L, Benegas R, Block J, et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 1994; 178:491-497.
5. Khalkhali I, Diggles LE, Taillefer R, Vandestreek PR, Peller PJ, Abdel-Nabi HH. Procedure guideline for breast scintigraphy. Society of Nuclear Medicine. J Nucl Med 1999; 40:1233-1235.
6. Buscombe JR. Scintimammography Imaging 2001; 13:163-170.
7. Liberman M, Samplais F, Mulder D, Sampalis JS. Breast cancer diagnosis by scintimammography: a meta-analysis and review of the literature. Breast Cancer Res Therapeutics 2003; 80:115-126.
8. Ballo MS, Sneige N. Can core needle biopsy replace fine-needle aspiration cytology in the diagnosis of palpable breast carcinoma. A comparative study of 124 women. Cancer 1996; 78:773-777.
9. Pijnappel RM, van den Donk M, Holland R, Mali WP, Peterse JL, Hendriks JH, Peeters PH. Diagnostic accuracy for different strategies of image-guided breast intervention in cases of nonpalpable breast lesions. Br J Cancer 2004; 90:595-600.
10. 99mTc-MIBI scintimammography in suspected breast cancer. J Nucl Med 1999; 40:296-301.
11. 99mTc-sestamibi breast imaging: Multi-center trial results. J Nucl Med 2000; 41:1973-1979.
12. 99mTc-MIBI scintimammography. Anticancer Res 1997; 17:1631-1634.
13. Palmedo H, Biersack HJ, Lastoria S. Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multi-centre trial. Eur J Nucl Med 1998; 25:375-385.
14. 99mtechnetium sestamibi. Am J Surg 2003; 185:544-549.
15. Lind P, Umschaden HW, Forsthuber E, Oman J, Kerschbaumer K, Gallowitsch HJ, et al. Scintimammography using Tc-99m tetrofosmin. Acta Med Austriaca 1997; 24:50-54.
16. m-sestamibi scintimammography in patients with suspicious breast lesions: comparison of SPET and planar images in the detection of primary tumours and axillary lymph node involvement. Nucl Med Commun 1997; 18:839-845.
17. Becherer A, Helbich T, Staudenherz Jakesz R, Kubista E, Lehner R, et al. The diagnostic value of planar and SPECT scintimammography in different age groups. Nucl Med Commun 1997; 18:338-340.
18. Helbech TH, Becherer A, Trattnig S, Leitha T, Kelkar P, Seifert M, et al. Differentiation of benign and malignant breast lesions: MR imaging vs sestamibi scintimammography. Radiology 1997; 202:421-429.
19. Mekhmandarov S, Sandbank J, Cohen, Lelcuk S, Lubin E. Technetium-99m-MIBI scintimammography in palpable and non-palpable breast lesions. J Nucl Med 1998; 39:86-91.
20. m-MIBI scintimammography in the evaluation of breast lesions and axillary involvement a comparison with mammography and histopathological diagnsosis. Nucl Med Commun 1999; 20:317-325.
21. Howarth D, Sillar R, Lan L, Clark D, Miles T. Scintimammography: An adjunctive test for the detection of breast cancer. Med J Aust 1999; 170:588-591.
22. 99mTc-sestamibi. Acta Radiol 1999; 40:394-399.
23. Buscombe JR, Cwikla JB, Holloway B, Hilson AJW. Prediction of the usefulness of combined mammography and scintimammography in suspected breast cancer using ROC curves. J Nucl Med 2000; 42:3-8.
24. 99mTc-sestamibi scintimammography in suspected breast cancer and axillary lymph node metastases detection. Eur J Surg Oncol 2001; 27:256-259.
25. Myslivecek M, Koranda P, Kaminek M, Husak V, Hartlova M, Duskova M, Cwiertka K. Technetium-99m MIBI scintimammography by planar and SPECT imaging in the diagnosis of breast carcinoma and axillary lymph node involvement. World J Nucl Med 2005; 4:159-164.
26. Tiling R, Kessler M, Untuch M, Sommer H, Linke R, Hahn K. Initial evaluation of breast cancer using Tc-99m sestamibi scintimammography. Eur J Radiol 2005; 53:206-212.
27. Bluemke DA, Gastonis CA, Chen MH, DeAngelis GA, DeBruhl N, Harms S. Magnetic resonance imaging of the breast prior to biopsy. J Am Med Assoc 2004; 292:2735-2742.
28. MARBIS study group. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multi-centre trial. Lancet 2005; 365:1769-1778.
29. 99mTc MIBI related to tumour size and type. Anticancer Res 1997; 17:1693-1694.
30. Buscombe JR, Cwikla JB, Thakrar DS, Hilson AJW. Prone SPECT scintimammography. Nucl Med Commun 1999; 20:237-245.
31. Buscombe JR, Kelleher SM, Parbhoo SP, Thakrar DS, Hinton J, Crow J, Hislon AJW. Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer selected for surgical biopsy. Clin Radiol 1998; 53:274-280.
32. 99mTc DMSA renal studies. Nucl Med Commun 1996; 17:549-553.
33. Peters AM, Bomanji J, Costa DC, Ell PJ, Gordon I, Henderson BL, Hilson AJ. Clinical audit in nuclear medicine. Nucl Med Commun 2004; 25:97-103.
34. Making the Best Use of a Department of Clinical Radiology, fifth edition. Guidelines for Doctors. London: Royal College of Radiologists; 2004.
35. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, et al. Breast scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging 2003; 30:BP107-BP114.
36. Buscombe JR, Holloway B, Roche N, Bombardieri E. Position of nuclear medicine modalities in the diagnostic work-up of breast cancer. Q J Nucl Med Mol Imaging 2004; 48:109-118.
37. Maublant J, de Latour M, Mestas D. Technetium-99m-sestamibi uptake in breast tumor and associated lymph nodes. J Nucl Med 1996; 37:922-925.
38. Taillefer R, Robidoux A, Turpin S, Lambert R, Cantin J, Leveille J. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer. J Nucl Med 1998; 39:459-464.
39. Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Drucker MJ, Livingston RB. Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography. Cancer 1999; 85:2410-2423.
40. Buscombe JR. Monitoring therapy in breast cancer. Nucl Med Commun 2002; 23:619-624.
41. 99mTc-MIBI scintigraphy. Radiat Med 1999; 17:389-391.
42. Cwikla JB, Kolasinska A, Buscombe JR, Hilson AJ. Tc-99m MIBI in suspected recurrent breast cancer. Cancer Biother Radiopharm 2000; 15:367-372.